MedTrace Logo

Effect of Dexmedetomidine on Postoperative Glucose and Insulin Levels.

NCT03809182 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2020-10-01

Study results available
· View outcomes & findings →

Summary

This study investigated the effect of dexmedetomidine in obese patients undergoing bariatric surgery.

Conditions

Interventions

DRUG

Dexmedetomidine

A bolus of 1ug/kg in 10 minutes, followed by an infusion of 0.5ug/kg/h until the end of surgery.

DRUG

0.9% Sodium-chloride

The same infusion rate used in the dexmedetomidine group.

DRUG

Fentanyl

Intraoperative fentanyl was given in case of 25% increment in the blood pressure and/or heart rate in comparison to baseline (previous anesthesia induction).

DRUG

Morphine Sulfate

Boluses of 3mg of intravenous morphine were given in the postoperative acute care unit. Once the pain score was equal or less than 3/10 the patient-controlled analgesia pumps were installed and the patients were discharged to their room.

Sponsors & Collaborators

  • Pontificia Universidad Catolica de Chile

    lead OTHER

Principal Investigators

  • Mauricio Ibacache, MD, PhD · Pontificia Universidad Catolica de Chile

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-09-27
Primary Completion
2013-07-25
Completion
2013-07-25

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03809182 on ClinicalTrials.gov